Chenglu Yuan
Qingdao University(CN)Zhejiang Chinese Medical University(CN)Affiliated Hospital of Qingdao University(CN)Qilu Hospital of Shandong University(CN)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Platelet Disorders and Treatments, Chronic Lymphocytic Leukemia Research, Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research
Most-Cited Works
- → A multicenter randomized open-label study of rituximab plus rhTPO vs rituximab in corticosteroid-resistant or relapsed ITP(2015)111 cited
- → High‐dose dexamethasone plus recombinant human thrombopoietin vs high‐dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial(2020)59 cited
- → Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial(2021)56 cited
- → A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia(2019)48 cited
- → The impact of response kinetics for multiple myeloma in the era of novel agents(2019)46 cited
- → The Functional TP53 rs1042522 and MDM4 rs4245739 Genetic Variants Contribute to Non-Hodgkin Lymphoma Risk